David Emerson Jorden, Acting Chief Financial Officer at PLx Pharma Inc. (PLXP), bought 65,454 shares at $6.88 ($450K) on 2017-06-14, disclosed to the SEC on 2017-06-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.88 | 32,727 | $225K | 50.0% |
| 2 | $6.88 | 32,727 | $225K | 50.0% |
| Total | $6.88 avg | 65,454 | $450K | 100% |
| Filing → |
| AURX | BUY | 2017-08-14 | $54K | — | Filing → |
| PrivateNuo Therapeutics, Inc. | BUY | 2016-07-29 | $138K | — | Filing → |
| CMXI | BUY | 2013-05-21 | $40K | — | Filing → |